Trials / Completed
CompletedNCT04708106
Characterization of Product Use in Smokers Switching From Cigarettes to a RELX Electronic Nicotine Delivery System
A Randomized, Multi-Center, Open-Label, Parallel-Cohort Study to Characterize Product Use in Smokers Switching From Combustible Cigarettes to a RELX Electronic Nicotine Delivery System (ENDS)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 194 (actual)
- Sponsor
- Cheerain HK Limited · Industry
- Sex
- All
- Age
- 22 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The study will assess product use behaviors, biomarkers of exposure, subjective effects, and safety in smokers who switch to a RELX ENDS over 8-weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | RELX ENDS Tobacco Flavor | Ad libitum use of the RELX ENDS Tobacco Flavor product |
| OTHER | RELX ENDS Menthol Flavor | Ad libitum use of the RELX ENDS Menthol product |
| OTHER | RELX ENDS Tobacco and Menthol Flavors | Ad libitum use of the RELX ENDS Tobacco and Menthol Flavor products |
Timeline
- Start date
- 2020-10-15
- Primary completion
- 2021-07-01
- Completion
- 2021-07-07
- First posted
- 2021-01-13
- Last updated
- 2021-07-22
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04708106. Inclusion in this directory is not an endorsement.